Materials of Interest

Current News

Ben Adams, The top 10 pharma R&D budgets in 2016, Fierce Biotech, April 26, 2017

Dana A. Elfin & Madi Alexander, Drug Industry May Face New Areas of Antitrust Scrutiny, Bloomberg BNA, April 10, 2017

Preetika Rana, China Emerges as Powerhouse for Biotech Drugs, Wall St. J., April 10, 2017

Lena H. Sun, The Trump administration is ill-prepared for a global pandemic, Wash. Post, April 9, 2017

Jeff Kolkey, Rockford lawsuit: Pharmaceutical company gouged city for drug used to treat babies, Rockford Reg. Star (rrstar.com), April 6, 2017

John McCormick & Jared S. Hopkins, Drugmaker Group's Ad Campaign Counters Trump's ‘Murder’ Charge, BNA Bloomberg, Mar. 31, 2017

Ed Taylor, Brazil Regulator Rejects Gilead Patent Request for Hepatitis C Drug, BNA Bloomberg, Mar. 31, 2017

As Health Care Debate Shifts, Senator Franken and Senate Colleagues Lead Milestone Effort to Bring Down Prescription Drug Prices, Press Release, March 29, 2017

FTC Press Release, Mallinckrodt Will Pay $100 Million to Settle FTC, State Charges It Illegally Maintained its Monopoly of Specialty Drug Used to Treat Infants, Jan. 18, 2017

UK Competition and Markets Authority, CMA fines Pfizer and Flynn £90 million for drug price hike to NHS, Press Release, Dec. 7, 2016

 


Nick Drager

Nick Drager, Accelerating TB Vaccine Research & Development Through Partnership, Global Pharmaceutical Regulation 2017, FSU College of Law, April 14, 2017

 

Jamie Love

Jerry Reichman

Jerome Reichman, Global Intellectual Property Strategies for a Redesigned Microbial Research CommonsGlobal Pharmaceutical Regulation 2017, FSU College of Law, April 14, 2017

Jerome H. Reichman, Paul F. Uhlir & Tom Dedeurwaerdere, Governing Digitally Integrated Genetic Resources, Data, and Literature (2016)

pre-publication full text  

info re volume